Rouses Point Pharm
Manufacturer Details
There are currently no manufacturer details available.
Rouses Point Pharm Drugs
-
![Propranolol Hydrochloride Er (Propranolol Hydrochloride) Capsule, Extended Release [Rouses Point Pharm]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c5091cd2-81c8-4ffe-b2aa-d053de5d6e12&name=propranolol-hydrochloride--2.jpg)
Propranolol Hydrochloride Er
General
Propranolol hydrochloride extended-release capsules provide propranolol hydrochloride in a sustained-release capsule for administration once daily. If patients are switched from propranolol hydrochloride tablets to propranolol hydrochloride extended-release capsules, care should be taken to assure that the desired therapeutic effect is maintained. Propranolol hydrochloride extended-release capsules should not be considered a simple mg-for-mg substitute for propranolol hydrochloride tablets. Propranolol hydrochloride extended-release capsules have different kinetics and produce lower blood levels. Retitration may be necessary, especially to maintain effectiveness at the end of the 24-hour dosing interval.
Hypertension
The usual initial dosage is 80 mg propranolol hydrochloride extended-release capsules once daily, whether used alone or added to a diuretic. The dosage may be increased to 120 mg once daily or higher until adequate blood pressure control is achieved. The usual maintenance dosage is 120 to 160 mg once daily. In some instances a dosage of 640 mg may be required. The time needed for full hypertensive response to a given dosage is variable and may range from a few days to several weeks.
Angina Pectoris
Starting with 80 mg propranolol hydrochloride extended-release capsules once daily, dosage should be gradually increased at three- to seven-day intervals until optimal response is obtained. Although individual patients may respond at any dosage level, the average optimal dosage appears to be 160 mg once daily. In angina pectoris, the value and safety of dosage exceeding 320 mg per day have not been established.
If treatment is to be discontinued, reduce dosage gradually over a period of a few weeks (see "WARNINGS").
Migraine
The initial oral dose is 80 mg propranolol hydrochloride extended-release capsules once daily. The usual effective dose range is 160 to 240 mg once daily. The dosage may be increased gradually to achieve optimal migraine prophylaxis. If a satisfactory response is not obtained within four to six weeks after reaching the maximal dose, propranolol hydrochloride extended-release capsules therapy should be discontinued. It may be advisable to withdraw the drug gradually over a period of several weeks depending on the patient's age, comorbidity, and dose of propranolol hydrochloride extended-release capsules.
Hypertrophic Subaortic Stenosis
The usual dosage is 80 to 160 mg propranolol hydrochloride extended-release capsules once daily.
-
![Nitroglycerin Aerosol, Metered [Rouses Point Pharm]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=3214ddac-e068-4306-8500-0fa90c8c5842&name=nitroglycerin-lingual-aerosol-8.jpg)
Nitroglycerin Aerosol
2.1 Recommended Dosage
At the onset of an attack, one metered spray or two metered sprays should be administered on or under the tongue. A spray may be repeated approximately every 5 minutes as needed. If two sprays are used initially, the patient may only administer one more spray after waiting 5 minutes. No more than 3 metered sprays are recommended within a 15-minute period. If chest pain persists after a total of 3 sprays, prompt medical attention is recommended. Nitroglycerin Lingual Aerosol may be used prophylactically 5 minutes to 10 minutes before engaging in activities that might precipitate an acute attack.
2.2 Priming the Container
After an initial priming of 10 sprays, each metered spray of Nitroglycerin Lingual Aerosol delivers 33 mg of solution containing 400 mcg of nitroglycerin. It will remain adequately primed for 6 weeks. If the product is not used within 6 weeks, it can be adequately re-primed with 2 sprays. Nitroglycerin Lingual Aerosol is available in either 200 metered sprays or 60 metered sprays per container, but the total number of available doses depends on the number of sprays per use (1 spray or 2 sprays), and the frequency of priming.
2.3 Administration
During use the patient should rest, ideally in the sitting position. The container should be held vertically with the valve head uppermost and the spray orifice as close to the mouth as possible. The dose should preferably be sprayed into the mouth on or under the tongue by pressing the button firmly and the mouth should be closed immediately after each dose. THE SPRAY SHOULD NOT BE INHALED. Patients should be instructed to familiarize themselves with the position of the spray orifice, which can be identified by the finger rest on top of the valve, in order to facilitate orientation for administration at night.
Do not shake container. Remove plastic cap. If this is the first time using the bottle, press actuator button 10 times to ensure proper dose priming (holding unit away from yourself and others). Hold container upright with forefinger on top of the actuator button. Open mouth and bring the container as close as possible. Press the actuator button firmly with forefinger to release spray(s) onto or under the tongue. Release button and close mouth. The medication should not be spit out or the mouth rinsed for 5 minutes to 10 minutes following administration. If a second administration is required to obtain relief, repeat steps 4, 5, and 6. No more than 3 metered sprays can be given within a 15-minute period. Replace plastic cover. If the product is not used for more than 6 weeks, then it can be adequately re-primed with 2 sprays.The level of the liquid in the container should be periodically checked. While the container is in the upright position, if the liquid reaches the top or middle of the hole on the side of the container, one should order more. When the liquid reaches the bottom of the hole, the remaining doses will have less than label content.
-
![Hydrocortisone Butyrate Cream [Rouses Point Pharm]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=fdf62f87-8b60-47ff-968a-0a5f0c8bc42f&name=hydrocortisone-butyrate-cream-2.jpg)
Hydrocortisone Butyrate
Hydrocortisone butyrate cream USP, 0.1% should be applied to the affected area as a thin film two or three times daily depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions.
If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.
-
![Hydrocortisone Butyrate Ointment [Rouses Point Pharm]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=2b549328-cabe-4ef2-9fb3-0fce52c75201&name=hydrocortisone-butyrate-ointment-2.jpg)
Hydrocortisone Butyrate Ointment
Hydrocortisone butyrate ointment, 0.1% should be applied to the affected area as a thin film two or three times daily depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions.
If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.
-
![Hydrocortisone Butyrate Solution [Rouses Point Pharm]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=7db9b9c4-9591-4ac4-abff-9c3c203cecb1&name=hydrocortisone-butyrate-solution-2.jpg)
Hydrocortisone Butyrate Solution
Hydrocortisone butyrate solution, 0.1% should be applied to the affected area as a thin film two or three times daily depending on the severity of the condition.
Sign Up for a Free Account